Does OFATUMUMAB Cause Concomitant disease aggravated? 58 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Concomitant disease aggravated have been filed in association with OFATUMUMAB (ARZERRA). This represents 0.2% of all adverse event reports for OFATUMUMAB.
58
Reports of Concomitant disease aggravated with OFATUMUMAB
0.2%
of all OFATUMUMAB reports
4
Deaths
16
Hospitalizations
How Dangerous Is Concomitant disease aggravated From OFATUMUMAB?
Of the 58 reports, 4 (6.9%) resulted in death, 16 (27.6%) required hospitalization.
Is Concomitant disease aggravated Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OFATUMUMAB. However, 58 reports have been filed with the FAERS database.
What Other Side Effects Does OFATUMUMAB Cause?
Fatigue (5,202)
Headache (4,430)
Pain (3,382)
Chills (3,372)
Pyrexia (3,370)
Influenza like illness (2,727)
Nausea (1,688)
Multiple sclerosis relapse (1,525)
Covid-19 (1,435)
Asthenia (1,393)
What Other Drugs Cause Concomitant disease aggravated?
SACUBITRIL\VALSARTAN (533)
SECUKINUMAB (461)
FINGOLIMOD (425)
MACITENTAN (286)
OMALIZUMAB (186)
SELEXIPAG (166)
METHOTREXATE (150)
RUXOLITINIB (142)
OCTREOTIDE (125)
BOSENTAN (123)
Which OFATUMUMAB Alternatives Have Lower Concomitant disease aggravated Risk?
OFATUMUMAB vs OFLOXACIN
OFATUMUMAB vs OLANZAPINE
OFATUMUMAB vs OLANZAPINE\SAMIDORPHAN L-MALATE
OFATUMUMAB vs OLAPARIB
OFATUMUMAB vs OLARATUMAB